Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ATR | Q13535 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.31 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.31 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.31 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.31 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56172 | 0.80 | — | — | |
| Methylamine SCHEMBL28903592 | 0.77 | GSR (0.33) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| SCHEMBL916303 | 0.76 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Water SCHEMBL8171778 | 0.76 | — | — | |
| Ammonia Solution, Strong SCHEMBL7105974 | 0.76 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| SCHEMBL5081844 | 0.76 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| SCHEMBL159013 | 0.76 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Fluoride SCHEMBL915482 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL2212601 | 0.76 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 | |
| Hydrochloric Acid SCHEMBL2212596 | 0.76 | GSR (0.36) | GSRGSTP1TXNRD1TXNRD3TXNRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2928476-A1 | COMPOUNDS, COMPOSITIONS AND METHODS USING E-SELECTIN ANTAGONISTS FOR MOBILIZATION OF HEMATOPOIETIC CELLS | GlycoMimetics, Inc. (US) | 2015-10-14 | — | — | EP | disclosed |
| EP-2794626-A1 | E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | GlycoMimetics, Inc. (US) | 2014-10-29 | — | — | EP | disclosed |
| WO-2014089269-A1 | COMPOUNDS, COMPOSITIONS AND METHODS USING E-SELECTIN ANTAGONISTS FOR MOBILIZATION OF HEMATOPOIETIC CELLS | GLYCOMIMETICS, INC. (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2013096926-A1 | E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | GLYCOMIMETICS, INC. (US) | 2013-06-27 | — | — | WO | disclosed |
| EP-2555779-A1 | GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV | GlycoMimetics, Inc. (US) | 2013-02-13 | — | — | EP | disclosed |
| WO-2012061662-A9 | GLYCOMIMETIC-PEPTIDOMIMETIC INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS | GLYCOMIMETICS, INC. (US) | 2012-12-06 | — | — | WO | disclosed |
| WO-2012061662-A1 | GLYCOMIMETIC-PEPTIDOMIMETIC INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS | GLYCOMIMETICS, INC. (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012047918-A1 | ANTI-EPILEPTOGENIC AGENTS | GLYCOMIMETICS, INC. (US) | 2012-04-12 | — | — | WO | disclosed |
| EP-2424544-A1 | HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS | GlycoMimetics, Inc. (US) | 2012-03-07 | — | — | EP | disclosed |
| WO-2011127179-A1 | GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV | GLYCOMIMETICS, INC. (US) | 2011-10-13 | — | — | WO | disclosed |
| WO-2009126556-A1 | PAN-SELECTIN INHIBITOR WITH ENHANCED PHARMACOKINETIC ACTIVITY | GLYCOMIMETICS, INC. (US) | 2009-10-15 | — | — | WO | disclosed |
| EP-2074132-A2 | GLYCOMIMETIC REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES | GlycoMimetics, Inc. (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009011889-A2 | COMPOUNDS AND METHODS FOR TREATMENT OF SICKLE CELL DISEASE OR COMPLICATIONS ASSOCIATED THEREWITH | GLYCOMIMETICS, INC. (US) | 2009-01-22 | — | — | WO | disclosed |
| EP-1934236-A1 | HETEROBIFUNCTIONAL PAN-SELECTIN INHIBITORS | GlycoMimetics, Inc. (US) | 2008-06-25 | — | — | EP | disclosed |
| WO-2008060378-A2 | GLYCOMIMETIC REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES | GLYCOMIMETICS, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008002449-A2 | GLYCOMIMETIC INHIBITORS OF SIGLEC-8 | GLYCOMIMETICS, INC. (US) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007028050-A1 | HETEROBIFUNCTIONAL PAN-SELECTIN INHIBITORS | GLYCOMIMETICS, INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2006127906-A1 | HETEROBIFUNCTIONAL COMPOUNDS FOR SELECTIN INHIBITION | GLYCOMIMETICS, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| EP-1685145-A2 | GLYCOMIMETIC ANTAGONISTS FOR BOTH E- AND P-SELECTINS | GlycoMimetics, Inc. (US) | 2006-08-02 | — | — | EP | disclosed |
| WO-2005054264-A2 | GLYCOMIMETIC ANTAGONISTS FOR BOTH E- AND P-SELECTINS | GLYCOMIMETICS, INC. (US) | 2005-06-16 | — | — | WO | disclosed |